1. Home
  2. YDES vs TIPT Comparison

YDES vs TIPT Comparison

Compare YDES & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$7.43

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Logo Tiptree Inc.

TIPT

Tiptree Inc.

HOLD

Current Price

$16.76

Market Cap

634.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDES
TIPT
Founded
2013
2007
Country
Taiwan
United States
Employees
N/A
1486
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
543.0M
634.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
YDES
TIPT
Price
$7.43
$16.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.2K
260.6K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
1.43%
EPS Growth
N/A
N/A
EPS
N/A
0.76
Revenue
N/A
$488,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$22.05
Revenue Growth
N/A
N/A
52 Week Low
$5.40
$15.49
52 Week High
$25.00
$27.38

Technical Indicators

Market Signals
Indicator
YDES
TIPT
Relative Strength Index (RSI) 45.61 52.28
Support Level N/A $16.41
Resistance Level $9.11 $18.15
Average True Range (ATR) 0.87 0.33
MACD 0.18 0.11
Stochastic Oscillator 60.24 80.89

Price Performance

Historical Comparison
YDES
TIPT

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About TIPT Tiptree Inc.

Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

Share on Social Networks: